首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human APP Abeta Recombinant Antibody(Solanezumab)

Anti-Human APP Abeta Recombinant Antibody(Solanezumab)

产品编号

YR1197

别名

科研级 Solanezumab ( 苏兰组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Solanezumab ( 苏兰组单抗 ), Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab
Catalog NumberYR1197
Molecular NameSolanezumab
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1 Kappa
FormulationPBS, pH7.5
BackgroundSolanezumab (proposed INN, LY2062430[1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector[2] for patients with Alzheimer's disease.[3][4] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.[5]
CAS Number955085-14-0
ApplicationWB, FuncS, IF, Neut, ELISA, FCM, IP
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetAPP Abeta[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价